Bibliography
- Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med 2005;20(19):1992-2001
- Poschet JF, Fazio JA, Timmins GS, Endosomal hyperacidification in cystic fibrosis is due to defective nitric oxide-cylic GMP signalling cascade. EMBO Rep 2006;7(5):553-9
- Antoniu SA. PDE5 inhibitors for cystic fibrosis: can they also enhance chloride transport? Evaluation of: Lubamba B, Lecourt H, Lebacq J, et al. Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis. Am J Respir Crit Care Med 2008;177(5):506-15. Expert Opin Investig Drugs 2008;17(6):965-68
- Lubamba B, Lecourt H, Lebacq J, Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis. Am J Respir Crit Care Med 2008;177(5):506-15
- Lubamba B, Lebacq J, Reychler G, Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice. Eur Respir J 2011;37(1):72-8
- Poschet JF, Timmins GS, Taylor-Cousar JL, Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2007;293(3):L712-19
- Robert R, Carlile GW, Pavel C, Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect. Mol Pharmacol 2008;73(2):478-89